Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

  • The PLOS ONE Staff

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

  • The PLOS ONE Staff
PLOS
x

In the article title, “Lap atinib” should be displayed as “Lapatinib.” The correct title is: Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. The correct citation is: Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. PLoS ONE 12(2): e0171356. doi:10.1371/journal.pone.0171356. The publisher apologizes for the error.

Reference

  1. 1. Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLoS ONE 12(2): e0171356. pmid:28158234